menu search

SXTP / 60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston

60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston
60 Degrees Pharma Presents Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting Read More
Posted: Oct 19 2023, 08:31
Author Name: GlobeNewsWire
Views: 091950

SXTP News  

60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston

By GlobeNewsWire
October 19, 2023

60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston

60 Degrees Pharma Presents Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meetin more_horizontal

60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference

By GlobeNewsWire
September 6, 2023

60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference

WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq: SXTP ), a pharmaceutical comp more_horizontal

Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 17% Today?

By InvestorPlace
July 13, 2023

Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 17% Today?

60 Degrees Pharmaceuticals (NASDAQ: SXTP ) stock is on the rise Thursday following the company's public debut yesterday. The public launch of SXTP sto more_horizontal


Search within

Pages Search Results: